Metopimazine

Chemical formula: C₂₂H₂₇N₃O₃S₂  Molecular mass: 445.6 g/mol 

Therapeutic indications

Metopimazine is indicated for:

Nausea, vomiting

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Nausea and vomiting
Nausea and additionally Vomiting

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Chemotherapy-induced vomiting

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Chemotherapy-induced nausea and vomiting
Vomiting and additionally Chemotherapy

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Chemotherapy-induced vomiting

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Chemotherapy-induced nausea and vomiting
Vomiting and additionally Chemotherapy

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Metopimazine is contraindicated in the following cases:

Risk of narrow-angle glaucoma

Angle-closure glaucoma

Risk of urinary retention linked to urethro-prostatic disorders

Disorder of prostate

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈